e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Immune mechanisms in the human lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device
John Dennis (Calgary, Canada), John Dennis, Andy Clark, Ian McAffer, Stefan Dalberg, Francis Green
Source:
International Congress 2015 – Immune mechanisms in the human lung
Session:
Immune mechanisms in the human lung
Session type:
Thematic Poster Session
Number:
4035
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
John Dennis (Calgary, Canada), John Dennis, Andy Clark, Ian McAffer, Stefan Dalberg, Francis Green. First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device. Eur Respir J 2015; 46: Suppl. 59, 4035
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Novel jet nebulizer/holding chamber for drug delivery to the deep lung
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
The utility of remote cough monitoring in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Patients’ opinion for their inhalation device. An assessment of convenience and use
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Is it feasible for respiratory physiologists to carry out inhaler device technique checks during routine pulmonary function tests?
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
Asthma management - The role of drug delivery
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005
Importance of inhalation device in asthma and COPD: A consensus using Delphi
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
An electrodeless, wearable system for simultaneous monitoring of cardiac and respiratory function
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
Inhalation technique education and its impact in asthma and COPD
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
GENebu Project: home nebulizer use and maintenance in Italy
Source: Eur Respir J 2001; 18: 758-763
Year: 2001
Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Antistatic valved holding chambers do not necessarily offer similar aerosol delivery performance
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Telemonitoring for management of asthma and other respiratory condition
Source: Annual Congress 2005 - Practical and scientific considerations in the use of new electronic technologies for ambulatory monitoring of respiratory disease
Year: 2005
Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Satisfaction survey on the use of breath actuated Inhaler
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Inspiratory flow resistance of marketed dry powder inhalers (DPI)
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014
Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept